The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007
20 November 2007 - 12:30AM
PR Newswire (US)
CHICAGO, Nov. 19 /PRNewswire-FirstCall/ -- The Female Health
Company (AMEX:FHC) today announced that it will host an investor
conference call to discuss its operating results for the quarter
and fiscal year ended September 30, 2007. The Company plans to
report its quarterly and year-end operating results on the morning
of Monday, November 26, 2007, and an investor conference call has
been scheduled for 11:00 a.m. Eastern Time (EST) on the same day.
Shareholders and other interested parties may participate in the
conference call by dialing 888-603-6873 (international participants
dial 973-582-2706) and referencing the conference ID 9473190, a few
minutes before 11:00 a.m. EST on November 26, 2007. A replay of the
call will be available through December 10, 2007 by dialing
877-519-4471 (international callers dial 973-341-3080), and
entering the conference ID 9473190. About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures
and markets the FC Female Condom(R), which is primarily distributed
by public health organizations and donor groups in over 90
developing countries around the world. World-wide, the Female
Condom is available in various programs in 108 countries. The
Company owns certain worldwide rights to the FC Female Condom(R),
including patents that have been issued in the United States,
United Kingdom, Japan, France, Italy, Germany, Spain, the European
Patent Convention, the People's Republic of China, Canada, South
Korea and Australia. FC Female Condom(R) is the only available
FDA-approved product controlled by a woman that offers dual
protection against sexually transmitted diseases, including
HIV/AIDS, and unintended pregnancy. "Safe Harbor" statement under
the Private Securities Litigation Reform Act of 1995: The
statements in this release which are not historical in fact are
forward-looking statements based upon the Company's current plans
and strategies, and reflect the Company's current assessment of the
risks and uncertainties related to its business, including such
things as product demand and market acceptance; the economic and
business environment and the impact of government actions; currency
risks; capacity; efficiency and supply constraints; and other risk
detailed in the Company's press releases, shareholder
communications and Securities and Exchange Commission filings.
Actual events affecting the Company and the impact of such events
upon the Company's operations may vary from those currently
anticipated. For more information about the Female Health Company
visit the Company's web site at http://www.femalehealth.com/ and
http://www.femalecondom.org/. To be added to the Company's e-mail
alert list, please send an e-mail to DATASOURCE: The Female Health
Company CONTACT: William R. Gargiulo, Jr., +1-231-526-1244, or
Donna Felch, CFO, +1-312-595-9123, both of The Female Health
Company Web site: http://www.femalehealth.com/
http://www.femalecondom.org/
Copyright
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Focus Morningstar Health Care Index Etf (American Stock Exchange): 0 recent articles
More The Female Health Company News Articles